BIOMAT Database Logo BIOMAT Database Logo

[Synthesis and tuberculostatic activity of various derivatives of 2-mercaptoimidazo [4,5-c] pyridine]. 1979

A Czarnocka-Janowicz, and J Sawlewicz, and J Jakubowski, and M Janowiec

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

A Czarnocka-Janowicz, and J Sawlewicz, and J Jakubowski, and M Janowiec
[Synthesis and tuberculostatic action of various 1-H-imidazo(4,5-c)pyridine derivatives].
January 1983, Acta poloniae pharmaceutica,
A Czarnocka-Janowicz, and J Sawlewicz, and J Jakubowski, and M Janowiec
Imidazo[4,5-b]pyridine derivatives of potential tuberculostatic activity, II: Synthesis and bioactivity of designed and some other 2-cyanomethylimidazo[4,5-b]pyridine derivatives.
September 1991, Archiv der Pharmazie,
A Czarnocka-Janowicz, and J Sawlewicz, and J Jakubowski, and M Janowiec
Imidazo[4,5-b]pyridine derivatives of potential tuberculostatic activity. Part 1: Synthesis and quantitative structure-activity relationships.
February 1991, Archiv der Pharmazie,
A Czarnocka-Janowicz, and J Sawlewicz, and J Jakubowski, and M Janowiec
3-(2-Imidazo[4,5-b]pyridine)propionic acid and some of its derivatives with suspected tuberculostatic activity.
April 1989, Die Pharmazie,
A Czarnocka-Janowicz, and J Sawlewicz, and J Jakubowski, and M Janowiec
New imidazo [4,5-b]pyridine carboxylic acids and their derivatives with expected tuberculostatic activity.
May 1988, Die Pharmazie,
A Czarnocka-Janowicz, and J Sawlewicz, and J Jakubowski, and M Janowiec
Synthesis and antiproliferative activity in vitro of new 2-thioxoimidazo[4,5-B]pyridine derivatives.
January 2015, Acta poloniae pharmaceutica,
A Czarnocka-Janowicz, and J Sawlewicz, and J Jakubowski, and M Janowiec
Synthesis and some reactions of 2-cyanomethylimidazo [4,5-b]pyridine. Tuberculostatic investigations of obtained compounds.
January 1986, Polish journal of pharmacology and pharmacy,
A Czarnocka-Janowicz, and J Sawlewicz, and J Jakubowski, and M Janowiec
Synthesis and some reactions of 1-methyl-1H-2-cyanomethyl-imidazo[4,5-b]pyridine. Tuberculostatic activity of obtained compounds.
December 1990, Die Pharmazie,
A Czarnocka-Janowicz, and J Sawlewicz, and J Jakubowski, and M Janowiec
Synthesis of some new 2-(substituted-phenyl)imidazo[4,5-c] and [4,5-b]pyridine derivatives and their antimicrobial activities.
August 2023, Molecular diversity,
A Czarnocka-Janowicz, and J Sawlewicz, and J Jakubowski, and M Janowiec
[Studies on pyrazine derivatives. XIX. Synthesis and tuberculostatic activity of various 3-phenoxy-2-pyrazinecarboxylic acid derivatives].
January 1983, Acta poloniae pharmaceutica,
Copied contents to your clipboard!